Get my own profile
Public access
View all183 articles
1 article
available
not available
Based on funding mandates
Co-authors
Steven A RosenbergNCIVerified email at nih.gov
Luca GattinoniLeibniz Institute for Immunotherapy (LIT)Verified email at lit.eu
Christopher A. Klebanoff, M.D.Associate Member, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Richard MorganCSO Be BiopharmaVerified email at be.bio
Mark E DudleyCSO, Instil BioVerified email at instilbio.com
Pawel MuranskiColumbia University Medical CenterVerified email at cumc.columbia.edu
WILLEM W OVERWIJKNektar TherapeuticsVerified email at nektar.com
Suzanne TopalianJohns Hopkins University School of MedicineVerified email at jhmi.edu
Madhusudhanan sukumarJanssen PharmaceuticalsVerified email at ITS.JNJ.com
Patrick HwuPresident and CEO, The Moffitt Cancer Center, Tampa, FLVerified email at moffitt.org
Rahul RoychoudhuriUniversity of CambridgeVerified email at cam.ac.uk
Steven E. Finkelstein, MD, DABR, FAC...Florida Cancer Affiliates / The US Oncology NetworkVerified email at usoncology.com
Sid KerkarKerkar Consulting LLCVerified email at kerkarconsulting.com
Zhili ZhengNational Cancer InstituteVerified email at mail.nih.gov
Suman VodnalaLyell ImmunopharmaVerified email at lyell.com
Robert EilOregon Health & Science UniversityVerified email at ohsu.edu
Vincenzo BronteVerona University HospitalVerified email at univr.it
Yutaka KawakamiKeio UniversityVerified email at keio.jp
Jonathan YewdellLaboratory of Viral Diseases, NIAID, NIHVerified email at nih.gov
Chyi-Chia Richard Lee, M.D., Ph.D.National Cancer Institute, National Institutes of HealthVerified email at mail.nih.gov